Literature DB >> 23698727

Aspirin resistance in patients undergoing hemodialysis and effect of hemodialysis on aspirin resistance.

Hale Unal Aksu1, Ender Oner2, Omer Celik2, Nilgun Isiksacan3, Huseyin Aksu2, Sami Uzun4, Derya Yavuz5, Savas Ozturk4, Mehmet Gul2, Nevzat Uslu2.   

Abstract

The aim of this study was to evaluate the prevalence of aspirin resistance (AR) in patients undergoing hemodialysis (HD) and to assess the effect of HD on the results of the Multiplate test. A total of 54 patients undergoing HD were included in this study. Blood samples were taken just before and after the HD session. To determine AR, we used Multiplate test. Platelet aggregation values of the study population were 363.01 ± 225.69 aggregation unit (AU) × minutes before and 375.33 ± 254.05 AU × minutes after the HD (P = .597). There was strong correlation between the values before and after HD (R = .755, P < .0001). The AR status was changed in 9 (16.6%) patients after HD. Agreement of AR status before and after HD was substantial (κ coefficient = .667, P < .0001). The prevalence of AR in patients undergoing HD seems higher than in most of the studied populations, and this study has shown that the AR statuses of a significant number of patients undergoing HD change after an HD session.
© The Author(s) 2013.

Entities:  

Keywords:  Multiplate test; aspirin resistance; hemodialysis

Mesh:

Substances:

Year:  2013        PMID: 23698727     DOI: 10.1177/1076029613489597

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  3 in total

Review 1.  Antiplatelet agents in hemodialysis.

Authors:  Massimiliano Migliori; Vincenzo Cantaluppi; Alessia Scatena; Vincenzo Panichi
Journal:  J Nephrol       Date:  2016-12-08       Impact factor: 3.902

2.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

3.  Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial.

Authors:  Christian Schoergenhofer; Eva-Luise Hobl; Michael Schwameis; Georg Gelbenegger; Thomas Staudinger; Gottfried Heinz; Walter S Speidl; Christian Zauner; Birgit Reiter; Irene Lang; Bernd Jilma
Journal:  Eur J Clin Invest       Date:  2017-06-20       Impact factor: 4.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.